Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „palbociclib“
Suchtreffer
Begriffe & Kennungen
Cholib · 4.5 · Concomitant administration of simvastatin with palbociclib is not recommended, because it may increase the ris
Eintrag öffnenCholib · 4.5 · Concomitant administration of simvastatin with palbociclib is not recommended, because it may increase the ris
Eintrag öffnenFaslodex · 4.8 · Combination therapy with palbociclib The overall safety profile of fulvestrant when used in combination with p
Eintrag öffnenFaslodex · 4.8 · Faslodex + Palbociclib Faslodex + placebo System Organ Class (N=345) (N=172) Frequency Preferred Terma All Gra
Eintrag öffnenFaslodex · 4.8 · In patients receiving fulvestrant in combination with palbociclib, the median time to first episode of any gra
Eintrag öffnenFulvestrant Mylan · 4.8 · 8 In patients receiving fulvestrant in combination with palbociclib, the median time to first episode of any g
Eintrag öffnenFulvestrant Mylan · 4.8 · Combination therapy with palbociclib The overall safety profile of fulvestrant when used in combination with p
Eintrag öffnenFulvestrant Mylan · 4.8 · Fulvestrant + Palbociclib Fulvestrant + placebo System Organ Class (N=345) (N=172) Frequency Preferred Terma A
Eintrag öffnenFulvestrant Mylan · 4.8 · Neutropenia In patients receiving fulvestrant in combination with palbociclib in the PALOMA3 study, neutropeni
Eintrag öffnenIbrance · 4.5 · 30 Palbociclib is primarily metabolised by CYP3A and sulphotransferase (SULT) enzyme SULT2A1. In vivo, palboci
Eintrag öffnenIbrance · 4.5 · 31 Drug-drug interaction between palbociclib and letrozole
Eintrag öffnenIbrance · 4.5 · Based on in vitro data, palbociclib is predicted to inhibit intestinal P-glycoprotein (P-gp) and breast cancer
Eintrag öffnenIbrance · 4.5 · Based on in vitro data, palbociclib is predicted to inhibit intestinal P-glycoprotein (P-gp) and breast cancer
Eintrag öffnenIbrance · 4.5 · Concomitant use of palbociclib with statins which are substrates of CYP3A4 and/or BCRP may increase the risk o
Eintrag öffnenIbrance · 4.5 · Concomitant use of palbociclib with statins which are substrates of CYP3A4 and/or BCRP may increase the risk o
Eintrag öffnenIbrance · 4.5 · DDI studies of palbociclib with oral contraceptives have not been conducted (see section 4.6).
Eintrag öffnenIbrance · 4.5 · DDI studies of palbociclib with oral contraceptives have not been conducted (see section 4.6).
Eintrag öffnenIbrance · 4.5 · Data from a DDI study in healthy male subjects indicated that palbociclib exposures were comparable when a sin
Eintrag öffnenIbrance · 4.5 · Data from a DDI study in healthy male subjects indicated that palbociclib exposures were comparable when a sin
Eintrag öffnenIbrance · 4.5 · Drug-drug interaction between palbociclib and fulvestrant
Eintrag öffnen